Literature DB >> 821733

Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata.

V C Jordan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 821733     DOI: 10.1016/0014-2964(76)90030-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  54 in total

1.  Profile of V. Craig Jordan.

Authors:  Sujata Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-16       Impact factor: 11.205

2.  A maternal diet high in n - 6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring.

Authors:  L Hilakivi-Clarke; R Clarke; I Onojafe; M Raygada; E Cho; M Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  Lifetime Genistein Intake Increases the Response of Mammary Tumors to Tamoxifen in Rats.

Authors:  Xiyuan Zhang; Katherine L Cook; Anni Warri; Idalia M Cruz; Mariana Rosim; Jeffrey Riskin; William Helferich; Daniel Doerge; Robert Clarke; Leena Hilakivi-Clarke
Journal:  Clin Cancer Res       Date:  2017-02-01       Impact factor: 12.531

4.  Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cells.

Authors:  N T Telang; R Narayanan; H L Bradlow; M P Osborne
Journal:  Breast Cancer Res Treat       Date:  1991-08       Impact factor: 4.872

Review 5.  Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer.

Authors:  V Craig Jordan
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

Review 6.  New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors:  V Craig Jordan
Journal:  Steroids       Date:  2007-07-27       Impact factor: 2.668

Review 7.  Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients.

Authors:  V Craig Jordan; Joan Lewis-Wambi; Helen Kim; Heather Cunliffe; Eric Ariazi; Catherine G N Sharma; Heather A Shupp; Ramona Swaby
Journal:  Breast       Date:  2007-08-24       Impact factor: 4.380

Review 8.  Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

9.  Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor.

Authors:  S J Zimniski; M E Brandt; D F Covey; D Puett
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 10.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.